CAS 635702-64-6 appears in our catalog under these names: Pazopanib HCl , Pazopanib Hydrochloride, Pazopanib Hydrochloride, >95% (HPLC), Pazopanib Hydrochloride, Pazopanib Hydrochloride/ 99.69% (existing batch purity). Offered by: Chemat Brand, TRC, Mikromol, GLPBio, TargetMol. Available pack sizes: on request, 100mg, 1g, 250mg, 25mg, 10mM (in 1ml dmso), 500mg, 10mg.
Pazopanib hydrochloride is a hydrochloride salt prepared from equimolar amounts of pazopanib and hydrochloric acid. Used for treatment of kidney cancer. It has a role as an antineoplastic agent, a tyrosine kinase inhibitor, an angiogenesis modulating agent and a vascular endothelial growth factor receptor antagonist. It contains a pazopanib(1+).
Source: ChEBI
| Molecular formula | C21H24ClN7O2S |
|---|---|
| Molecular weight | 474.0 g/mol |
| IUPAC name | 5-[[4-[(2,3-dimethylindazol-6-yl)-methylamino]pyrimidin-2-yl]amino]-2-methylbenzenesulfonamide;hydrochloride |
| InChIKey | MQHIQUBXFFAOMK-UHFFFAOYSA-N |
| SMILES | CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N.Cl |
Computed by PubChem (NCBI)